S06771 Summary:

BILL NOS06771
 
SAME ASSAME AS A09098
 
SPONSORMAZIARZ
 
COSPNSRGRISANTI, PARKER
 
MLTSPNSR
 
Add S6505-d, Ed L
 
Establishes licensure procedure for prescribers of controlled substances including definitions, training, training accreditation and further requirements.
Go to top    

S06771 Actions:

BILL NOS06771
 
03/07/2014REFERRED TO HIGHER EDUCATION
04/29/2014REPORTED AND COMMITTED TO HEALTH
Go to top

S06771 Floor Votes:

There are no votes for this bill in this legislative session.
Go to top

S06771 Text:



 
                STATE OF NEW YORK
        ________________________________________________________________________
 
                                          6771
 
                    IN SENATE
 
                                      March 7, 2014
                                       ___________
 
        Introduced  by  Sen. MAZIARZ -- read twice and ordered printed, and when
          printed to be committed to the Committee on Higher Education
 
        AN ACT to amend the education law, in relation to maintenance of  licen-
          sure for prescribers of controlled substances
 
          The  People of the State of New York, represented in Senate and Assem-
        bly, do enact as follows:
 

     1    Section 1. The education law is amended by adding a new section 6505-d
     2  to read as follows:
     3    § 6505-d. Coursework  or  training  for  maintenance  of  professional
     4  licensure.  1.  In  order  to  maintain his or her professional license,
     5  every prescriber shall complete the coursework or training described  in
     6  this  section  relating  to  the treatment and management of patients to
     7  whom controlled substances are prescribed.  For  the  purposes  of  this
     8  section, the following terms shall have the following meanings:
     9    (a) "Prescriber" shall mean any practitioner that is (i) authorized to
    10  prescribe  controlled  substances  to a human patient pursuant to his or
    11  her licensed professional practice, and (ii) registered under the feder-

    12  al controlled substances act and in possession of a registration  number
    13  from  the  drug  enforcement administration, United States department of
    14  justice, or its successor agency.
    15    (b) "High volume prescriber" shall mean  a  prescriber  that  (i)  has
    16  thirty or more patients being treated for chronic pain for whom any dose
    17  of  an  opioid  has  been prescribed for ninety or more continuous days,
    18  and/or (ii) has at least one patient for whom a daily dose of  at  least
    19  one  hundred  milligrams  of  morphine  or its equivalent was prescribed
    20  within the past twelve months.
    21    2. (a) Within available appropriations or from other  funds  appropri-
    22  ated for the purposes of this section, the office of the professions, in

    23  consultation  with the department of health and the office of alcoholism
    24  and substance abuse services, shall establish an expert-level work group
    25  to develop content areas, evidence-based curricula, and  outcomes  meas-
    26  urement methods for coursework or training relating to the treatment and
    27  management  of  patients  to  whom controlled substances are prescribed.
    28  Such work group shall be composed of no less than seven individuals  and
 
         EXPLANATION--Matter in italics (underscored) is new; matter in brackets
                              [ ] is old law to be omitted.
                                                                   LBD14237-02-4

        S. 6771                             2
 

     1  shall  consist  of  practicing  physicians or other prescribers, pharma-
     2  cists, addiction medicine experts,  experts  in  medical  education  and
     3  delivery of educational programs, and at least one parent or other advo-
     4  cate  for  children  with addiction. The members of the work group shall
     5  not have any direct relationship to any pharmaceutical  company  or  any
     6  organization representing the interests of pharmaceutical companies. The
     7  members  of  the  work group shall be selected within one hundred eighty
     8  days of the effective date of this section. Members of  the  work  group
     9  shall  receive  no compensation for their services, but shall be allowed
    10  actual and necessary expenses in the performance of their duties  pursu-
    11  ant to this section.

    12    (b)  The  coursework  or  training  developed  by  the  work group may
    13  include, but not be limited to, instruction  in  the  following  subject
    14  areas:  (i)  requirements  of  the  internet  system  for  tracking over
    15  prescribing (I-STOP) act; (ii) federal drug enforcement agency  require-
    16  ments  relating  to  prescribing  controlled  substances; (iii) managing
    17  acute pain;  (iv)  managing  addiction  including  but  not  limited  to
    18  prevention, screening and intervention for at-risk behavior, identifica-
    19  tion  of  addiction,  and treatment referrals; (v) opioid and non-opioid
    20  pain management; (vi) dosing and monitoring for all prescription  drugs;
    21  (vii)  prescribing  guidelines  for  all  prescription drugs; and (viii)

    22  specialty care referrals for pain, mental  health  and  substance  abuse
    23  disorders.  In  developing  the  content  areas, curricula, and outcomes
    24  measurement methods for such coursework or training, the work group  may
    25  also  include instruction substantially similar to the courses described
    26  in the federal Drug Addiction Treatment Act  of  2000  relating  to  the
    27  treatment  and  management  of  opioid-addicted patients. The work group
    28  shall, to the maximum extent  practicable,  develop  the  coursework  or
    29  training in such a manner that it shall qualify for credit in connection
    30  with existing continuing medical education requirements for prescribers.
    31  The coursework or training developed by the work group may be structured

    32  as  one course or as multiple courses. The work group shall complete the
    33  development of the content areas, curricula, and  outcomes  measurements
    34  methods within twelve months of the effective date of this section.
    35    (c)  Upon completion of the development of the coursework or training,
    36  the office of the professions shall take  actions  necessary  to  obtain
    37  accreditation  of such coursework or training by the accreditation coun-
    38  cil for continuing medical education or its designees. The office of the
    39  professions may take such actions for accreditation on  its  own  or  in
    40  collaboration with one or more statewide medical associations, specialty
    41  medical boards, and/or state university medical schools.

    42    3.  The  coursework  or  training  developed  by the work group may be
    43  provided by: (a) the department; (b)  the  department  in  collaboration
    44  with  one  or  more  statewide  medical  associations, specialty medical
    45  boards, and/or state university medical schools; and/or (c)  any  organ-
    46  ization  that  the  commissioner  determines  to  be appropriate for the
    47  purposes of this section.  Such coursework or training may be offered in
    48  a classroom setting, through internet-based instruction,  or  otherwise,
    49  as approved by the commissioner.
    50    4.  (a)  In order to satisfy the maintenance of licensure requirements
    51  set forth in this section, a prescriber shall complete  at  least  three

    52  hours  of  coursework or training developed by the work group which must
    53  include, among other things, instruction on prescription drug addiction;
    54  provided however, that a high volume prescriber shall complete at  least
    55  eight  hours of coursework or training developed by the work group which
    56  must include, among other things, instruction on the use of opioids  for

        S. 6771                             3
 
     1  the management of chronic pain. Each prescriber and high volume prescri-
     2  ber shall complete such coursework prior to his or her next registration
     3  or re-registration, but in no event shall such coursework or training be
     4  taken  less  than  once  every  five  years.    Documentation  of course

     5  completion shall be provided to the department by a prescriber  or  high
     6  volume prescriber in order to maintain his or her professional license.
     7    (b)  The  department,  in  consultation with the department of health,
     8  shall provide an exemption from the requirements of this section to  any
     9  prescriber  who requests such an exemption and who shows, to the depart-
    10  ment's satisfaction, that such prescriber is not subject to the require-
    11  ments of this section. The department  may,  in  consultation  with  the
    12  department  of  health,  provide  an exemption to other prescribers that
    13  demonstrate to the department's satisfaction that such prescriber's  use
    14  of  controlled  substances is limited exclusively to use in an operating

    15  room or to use in other substantially similar circumstances.
    16    5. The maintenance of licensure requirements set forth in this section
    17  may also be satisfied by completion of a course or  courses  similar  to
    18  the  coursework  or  training  developed by the work group provided that
    19  such course or courses: (a) are provided by a member board of the Ameri-
    20  can board of medical specialties as part of its maintenance  of  certif-
    21  ication  process or are provided by any other organization determined by
    22  the commissioner to be appropriate for the purposes of this section; (b)
    23  satisfy the applicable hour requirements set forth in paragraph  (a)  of
    24  subdivision  four  of this section; (c) are substantially similar to the

    25  coursework or training developed by the work group as determined by  the
    26  office  of  the  professions;  and (d) are approved by the office of the
    27  professions.
    28    6.  The provisions of this section shall not apply to  any  prescriber
    29  that  is  certified  by  a member board of the American board of medical
    30  specialties until such time as such  member  board  has  integrated  the
    31  coursework or training required by this section into such member board's
    32  existing  maintenance  of certification process; provided, however, that
    33  the provisions of this section shall apply to such prescribers no  later
    34  than twenty-four months after this section shall take effect.
    35    § 2. This act shall take effect immediately.
Go to top